Listed

DataMeds AI, Inc.

MEDSNasdaqCIK 2030763Consumer discretionaryFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$1.8mRevenue, Q2 FY2026, three months to 2026-06-30$1.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-17, accession 0001493152-26-038581.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 17, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$1.8mRevenue, Q2 FY2026, three months to 2026-06-30$1.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-17, accession 0001493152-26-038581.Report this figure−77.2% on a year earlier
  • Gross margin10.2%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $182.2k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-17, accession 0001493152-26-038581.Revenue: $1.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-17, accession 0001493152-26-038581.Report this figure+3.7 pts on a year earlier
  • Operating margin−412.7%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$7.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-17, accession 0001493152-26-038581.Revenue: $1.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-17, accession 0001493152-26-038581.Report this figure−342.1 pts on a year earlier
  • Net margin−1031.7%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$18.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-17, accession 0001493152-26-038581.Revenue: $1.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-17, accession 0001493152-26-038581.Report this figure−946.1 pts on a year earlier
  • Diluted EPS−$7.13Diluted EPS, Q2 FY2026, three months to 2026-06-30−$7.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-17, accession 0001493152-26-038581.Report this figure−32.0% on a year earlier
  • Free cash flownot reported (Capital expenditure not reported)No year-earlier figure to compare

Last eight quarters

Full statements
Revenue$1.8mGross margin 10.2%
Diluted EPS−$7.13, Q2 FY2026
DataMeds AI, Inc., key figures for the last eight quarters
Line itemUnitperiod not labelled2024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$m5.7Revenue, period not labelled, three months to 2024-09-30$5.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-19, accession 0001493152-25-024328.Report this figure12.4Revenue, Q4 FY2024, three months to 2024-12-31$12.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-20, accession 0001493152-26-012004. Derived: 12-month figure less the 9-month figure.Report this figure10.9Revenue, Q1 FY2025, three months to 2025-03-31$10.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-19, accession 0001493152-26-024413.Report this figure7.8Revenue, Q2 FY2025, three months to 2025-06-30$7.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-17, accession 0001493152-26-038581.Report this figure3.0Revenue, Q3 FY2025, three months to 2025-09-30$3.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-19, accession 0001493152-25-024328.Report this figure1.7Revenue, Q4 FY2025, three months to 2025-12-31$1.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-20, accession 0001493152-26-012004. Derived: 12-month figure less the 9-month figure.Report this figure1.6Revenue, Q1 FY2026, three months to 2026-03-31$1.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-19, accession 0001493152-26-024413.Report this figure1.8Revenue, Q2 FY2026, three months to 2026-06-30$1.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-17, accession 0001493152-26-038581.Report this figure
Gross margin%9.2%Gross margin, period not labelled, three months to 2024-09-30. gross profit / revenueGross profit: $521.2k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-19, accession 0001493152-25-024328.Revenue: $5.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-19, accession 0001493152-25-024328.Report this figure10.1%Gross margin, Q4 FY2024, three months to 2024-12-31. gross profit / revenueGross profit: $1.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-20, accession 0001493152-26-012004. Derived: 12-month figure less the 9-month figure.Revenue: $12.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-20, accession 0001493152-26-012004. Derived: 12-month figure less the 9-month figure.Report this figure6.4%Gross margin, Q1 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $692.6k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-19, accession 0001493152-26-024413.Revenue: $10.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-19, accession 0001493152-26-024413.Report this figure6.5%Gross margin, Q2 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $505.8k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-17, accession 0001493152-26-038581.Revenue: $7.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-17, accession 0001493152-26-038581.Report this figure7.7%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $231.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-19, accession 0001493152-25-024328.Revenue: $3.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-19, accession 0001493152-25-024328.Report this figure(470.2%)Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: −$7.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-20, accession 0001493152-26-012004. Derived: 12-month figure less the 9-month figure.Revenue: $1.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-20, accession 0001493152-26-012004. Derived: 12-month figure less the 9-month figure.Report this figure10.9%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $170.2k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-19, accession 0001493152-26-024413.Revenue: $1.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-19, accession 0001493152-26-024413.Report this figure10.2%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $182.2k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-17, accession 0001493152-26-038581.Revenue: $1.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-17, accession 0001493152-26-038581.Report this figure
Operating margin%(30.8%)Operating margin, period not labelled, three months to 2024-09-30. operating income / revenueOperating income: −$1.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-19, accession 0001493152-25-024328.Revenue: $5.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-19, accession 0001493152-25-024328.Report this figure(30.2%)Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: −$3.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-20, accession 0001493152-26-012004. Derived: 12-month figure less the 9-month figure.Revenue: $12.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-20, accession 0001493152-26-012004. Derived: 12-month figure less the 9-month figure.Report this figure(288.6%)Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: −$31.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-19, accession 0001493152-26-024413.Revenue: $10.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-19, accession 0001493152-26-024413.Report this figure(70.6%)Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: −$5.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-17, accession 0001493152-26-038581.Revenue: $7.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-17, accession 0001493152-26-038581.Report this figure(1047.1%)Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: −$31.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-19, accession 0001493152-25-024328.Revenue: $3.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-19, accession 0001493152-25-024328.Report this figure(1517.5%)Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: −$25.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-20, accession 0001493152-26-012004. Derived: 12-month figure less the 9-month figure.Revenue: $1.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-20, accession 0001493152-26-012004. Derived: 12-month figure less the 9-month figure.Report this figure(385.7%)Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: −$6.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-19, accession 0001493152-26-024413.Revenue: $1.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-19, accession 0001493152-26-024413.Report this figure(412.7%)Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$7.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-17, accession 0001493152-26-038581.Revenue: $1.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-17, accession 0001493152-26-038581.Report this figure
Net margin%(32.9%)Net margin, period not labelled, three months to 2024-09-30. net income / revenueNet income: −$1.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-19, accession 0001493152-25-024328.Revenue: $5.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-19, accession 0001493152-25-024328.Report this figure(34.9%)Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: −$4.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-20, accession 0001493152-26-012004. Derived: 12-month figure less the 9-month figure.Revenue: $12.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-20, accession 0001493152-26-012004. Derived: 12-month figure less the 9-month figure.Report this figure(298.5%)Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: −$32.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-17, accession 0001493152-26-038581.Revenue: $10.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-19, accession 0001493152-26-024413.Report this figure(85.6%)Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: −$6.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-17, accession 0001493152-26-038581.Revenue: $7.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-17, accession 0001493152-26-038581.Report this figure(1139.0%)Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: −$34.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-19, accession 0001493152-25-024328.Revenue: $3.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-19, accession 0001493152-25-024328.Report this figure(1667.2%)Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: −$27.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-20, accession 0001493152-26-012004. Derived: 12-month figure less the 9-month figure.Revenue: $1.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-20, accession 0001493152-26-012004. Derived: 12-month figure less the 9-month figure.Report this figure(496.5%)Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: −$7.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-17, accession 0001493152-26-038581.Revenue: $1.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-19, accession 0001493152-26-024413.Report this figure(1031.7%)Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$18.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-17, accession 0001493152-26-038581.Revenue: $1.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-17, accession 0001493152-26-038581.Report this figure
Diluted EPS$ per share(0.04)Diluted EPS, period not labelled, three months to 2024-09-30−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-19, accession 0001493152-25-024328.Report this figurenot reported (Diluted EPS not reported)(0.62)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.62 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-19, accession 0001493152-26-024413.Report this figure(5.40)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$5.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-17, accession 0001493152-26-038581.Report this figure(0.46)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-19, accession 0001493152-25-024328.Report this figurenot reported (Diluted EPS not reported)(0.07)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-19, accession 0001493152-26-024413.Report this figure(7.13)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$7.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-17, accession 0001493152-26-038581.Report this figure
Free cash flow$mnot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$23.3mGross margin −27.5%
Diluted EPS−$1.43, FY2025
DataMeds AI, Inc., key figures for the last five fiscal years
Line itemUnitFY2023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$mnot reported (Revenue not reported)18.1Revenue, FY2024, twelve months to 2024-12-31$18.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-20, accession 0001493152-26-012004.Report this figure23.3Revenue, FY2025, twelve months to 2025-12-31$23.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-20, accession 0001493152-26-012004.Report this figure
Gross margin%not reported (Gross profit and Revenue not reported)9.7%Gross margin, FY2024, twelve months to 2024-12-31. gross profit / revenueGross profit: $1.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-20, accession 0001493152-26-012004.Revenue: $18.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-20, accession 0001493152-26-012004.Report this figure(27.5%)Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: −$6.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-20, accession 0001493152-26-012004.Revenue: $23.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-20, accession 0001493152-26-012004.Report this figure
Operating margin%not reported (Revenue not reported)(33.9%)Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: −$6.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-20, accession 0001493152-26-012004.Revenue: $18.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-20, accession 0001493152-26-012004.Report this figure(401.7%)Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: −$93.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-20, accession 0001493152-26-012004.Revenue: $23.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-20, accession 0001493152-26-012004.Report this figure
Net margin%not reported (Revenue not reported)(37.8%)Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: −$6.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-20, accession 0001493152-26-012004.Revenue: $18.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-20, accession 0001493152-26-012004.Report this figure(433.9%)Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: −$101.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-20, accession 0001493152-26-012004.Revenue: $23.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-20, accession 0001493152-26-012004.Report this figure
Diluted EPS$ per share(0.06)Diluted EPS, period not labelled, twelve months to 2023-12-31−$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-03-25, accession 0001641172-25-000612.Report this figure(0.15)Diluted EPS, FY2024, twelve months to 2024-12-31−$0.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-20, accession 0001493152-26-012004.Report this figure(1.43)Diluted EPS, FY2025, twelve months to 2025-12-31−$1.43 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-20, accession 0001493152-26-012004.Report this figure
Free cash flow$mnot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding DataMeds AI, Inc.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
JANE STREET GROUP, LLC2026-06-30$63.6k20,532New+20,532
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$38.6k12,467New+12,467
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$34.4k11,085New+11,085
VANGUARD FIDUCIARY TRUST CO2026-06-30$19.2k6,191New+6,191
BARCLAYS PLC2026-06-30$2.2k723New+723
Tower Research Capital LLC (TRC)2026-06-30$2.1k678New+678
Fortitude Family Office, LLC2026-06-30$366118New+118
Integrated Wealth Concepts LLC2026-06-30$7825New+25
Global Retirement Partners, LLC2026-06-30$62Not compared
DANSKE BANK A/S2026-06-30$31New+1

Recent filings

All 175 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

DataMeds AI, Inc., recent filings
FiledFormWhat it isAccession number
2026-10-2617:00 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-048573
2026-10-2009:24 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-26-047711
2026-10-1617:15 ET8-K1.01 Entry into a material agreement; 3.01 Delisting notice; 3.02 Unregistered sale of equity0001493152-26-047451
2026-10-1317:27 ET8-K8.01 Other events0001493152-26-046887
2026-10-0917:20 ETS-1/ARegistration statement, amended0001493152-26-046608
2026-09-1717:23 ET8-K8.01 Other events0001493152-26-043169
2026-09-1617:11 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-042951
2026-08-1807:43 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-26-038891
2026-08-1706:05 ET10-QQuarterly reportPeriod 2026-06-300001493152-26-038581
2026-08-1416:46 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-26-038475

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Mar 20, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
2030763
Tickers
MEDS
Exchange
Nasdaq
SIC code
5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries
Sector
Consumer discretionary
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
<br>Emerging growth company
Former names
Wellgistics Health, Inc. (to 2026-07-21); Danam Health, Inc (to 2024-09-27)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 17:01 ET. Listed shows no prices and gives no investment advice.